DELTA-FLY PHARM

#713 COMPANY RANKING
Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323 to treat lung cancer; DFP-17729, DFP-11207, and DFP-14927 for the treatment of solid tumors; and DFP-10825 for peritoneal metastasis. The company was founded in 2010 and is headquartered in Tokushima, Japan.
ninja emoji
13 emps
light emoji
Since 2010

Delta-Fly Pharm's Related Companies

Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.

Representing this company? Click here to claim and customize this page!

Reviews About Delta-Fly Pharm

avatar

Delta-Fly Pharm WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!